These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9350384)

  • 1. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.
    Gijsman H; Kramer MS; Sargent J; Tuchman M; Matzura-Wolfe D; Polis A; Teall J; Block G; Ferrari MD
    Cephalalgia; 1997 Oct; 17(6):647-51. PubMed ID: 9350384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
    Teall J; Tuchman M; Cutler N; Gross M; Willoughby E; Smith B; Jiang K; Reines S; Block G
    Headache; 1998 Apr; 38(4):281-7. PubMed ID: 9595867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
    Visser WH; Terwindt GM; Reines SA; Jiang K; Lines CR; Ferrari MD
    Arch Neurol; 1996 Nov; 53(11):1132-7. PubMed ID: 8912486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
    Winner P; Lewis D; Visser WH; Jiang K; Ahrens S; Evans JK;
    Headache; 2002 Jan; 42(1):49-55. PubMed ID: 12005275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.
    Pascual J; Vega P; Diener HC; Allen C; Vrijens F; Patel K
    Cephalalgia; 2000 Jun; 20(5):455-61. PubMed ID: 11037741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of MK-462 in migraine.
    Cutler NR; Claghorn J; Sramek JJ; Block G; Panebianco D; Cheng H; Olah TV; Reines SA
    Cephalalgia; 1996 Apr; 16(2):113-6. PubMed ID: 8665577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
    Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F
    Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in migraine-specific quality of life in a clinical trial of rizatriptan.
    Santanello NC; Polis AB; Hartmaier SL; Kramer MS; Block GA; Silberstein SD
    Cephalalgia; 1997 Dec; 17(8):867-72; discussion 800. PubMed ID: 9453276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M; Faulds D
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.
    Ho TW; Pearlman E; Lewis D; Hämäläinen M; Connor K; Michelson D; Zhang Y; Assaid C; Mozley LH; Strickler N; Bachman R; Mahoney E; Lines C; Hewitt DJ;
    Cephalalgia; 2012 Jul; 32(10):750-65. PubMed ID: 22711898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.
    Ferrari MD; Loder E; McCarroll KA; Lines CR
    Cephalalgia; 2001 Mar; 21(2):129-36. PubMed ID: 11422095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
    Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rizatriptan: an update of its use in the management of migraine.
    Wellington K; Plosker GL
    Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
    Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
    Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
    Ahrens SP; Farmer MV; Williams DL; Willoughby E; Jiang K; Block GA; Visser WH
    Cephalalgia; 1999 Jun; 19(5):525-30. PubMed ID: 10403069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
    MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.